Biomarker
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- cfDNA
- DNA
- Education
- End of Treatment
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Innovation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- oncoanalyser
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Re-use data
- Research
- Scientific publications
- Treatment
- Uncategorized
- Whole genome sequencing
- Working in the cloud
Towards a learning healthcare system by broad collaboration
15-09-2022
Developing a new drug is expensive and takes a long time. In addition, there is only a slim chance that …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
11-08-2022
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
14-04-2022
The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …
SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found
23-07-2020
At Hartwig we “analyse sequenced tumor DNA”. This is something we try to continuously improve. These analyses are shared with …
Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights
19-10-2019
For the first time, Dutch researchers have created a detailed overview of the landscape of DNA-deviations in thousands of metastatic …
It is important to unravel the DNA in rare types of cancer; 21% of patients with cancer have a rare form.
Internist-oncologist and Professor of Rare Cancers at Radboudumc